Potapenko Kateryna, Lisiutin Gennadii, Vasylieva Nataliia, Strashnova Iryna, Franke Raimo, Petriv Nataliia, Duduyemi Oladimeji Paul, Baklan Kyrylo, Korotaieva Nadiia, Gudzenko Tetyana, Manns Michael P, Broenstrup Mark, Lenzen Henrike, Vital Marius, Ivanytsia Volodymyr, Yevsa Tetyana
Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hannover, Germany; Department of Microbiology, Virology, and Biotechnology, Odesa I. I. Mechnykov National University, Odesa, Ukraine.
Department of Microbiology, Virology, and Biotechnology, Odesa I. I. Mechnykov National University, Odesa, Ukraine.
Biomed Pharmacother. 2025 May;186:117981. doi: 10.1016/j.biopha.2025.117981. Epub 2025 Mar 27.
We investigated the antimicrobial and anticancer capacity of secondary metabolites from six strains of marine actinobacteria belonging to the genus Streptomyces. Bacteria strains were isolated from the Black Sea and identified using 16S rRNA gene sequencing. Exometabolites were extracted using ethyl acetate. Antagonistic activity was investigated by agar block-diffusion method against ten strains of indicator microorganisms. The anticancer activities of the extracts were assessed on murine cholangiocarcinoma (CCA) cells while normal mouse fibroblasts CBA-310 served as a control. The extracts were tested as monotherapy or in combination with a standard chemotherapeutic drug for CCA, gemcitabine. Cell proliferation and viability were assessed using crystal violet and cell counting kit-8 assays. The induction of cellular senescence was investigated by senescence-associated β-galactosidase assay. Fluorescence-activated cell sorting analysis was used to determine cellular apoptosis and necroptosis. Liquid chromatography-mass spectrometry (LC-MS/MS) analysis was used to define the main players in the extracts. Streptomyces strains showed antagonistic activity against at least one indicator microorganism. Two extracts, S. ambofaciens (Myt 8) and S. globisporus ONU 1019 (Myt 11), displayed anticancer activity. Extracts Myt 8 and Myt 11 alone or in combination with low doses of gemcitabine inhibited CCA cells in a time and dose-dependent manner and induced early apoptosis and cellular senescence. LC-MS/MS analysis identified daidzein, germicidin, staurosporine alpha-curcumene, and alpha-calacorene - with potential antibacterial and anticancer effects. Streptomyces extracts showed antimicrobial and anticancer properties, potentially reducing chemotherapy doses for CCA. These findings suggest a dual therapeutic role against infections and CCA, warranting further in vivo studies.
我们研究了链霉菌属6株海洋放线菌次生代谢产物的抗菌和抗癌能力。从黑海分离出细菌菌株,并使用16S rRNA基因测序进行鉴定。用乙酸乙酯提取胞外代谢产物。采用琼脂块扩散法对10株指示微生物进行拮抗活性研究。提取物的抗癌活性在小鼠胆管癌细胞(CCA)上进行评估,同时以正常小鼠成纤维细胞CBA - 310作为对照。提取物单独或与CCA的标准化疗药物吉西他滨联合进行测试。使用结晶紫和细胞计数试剂盒 - 8检测法评估细胞增殖和活力。通过衰老相关β - 半乳糖苷酶检测法研究细胞衰老的诱导情况。采用荧光激活细胞分选分析来确定细胞凋亡和坏死性凋亡。利用液相色谱 - 质谱联用(LC - MS/MS)分析来确定提取物中的主要成分。链霉菌菌株对至少一种指示微生物表现出拮抗活性。两种提取物,即产二素链霉菌(Myt 8)和球形链霉菌ONU 1019(Myt 11),具有抗癌活性。提取物Myt 8和Myt 11单独或与低剂量吉西他滨联合使用,以时间和剂量依赖的方式抑制CCA细胞,并诱导早期凋亡和细胞衰老。LC - MS/MS分析鉴定出大豆苷元、杀菌素、星形孢菌素、α - 姜黄烯和α - 卡拉考烯,它们具有潜在的抗菌和抗癌作用。链霉菌提取物显示出抗菌和抗癌特性,可能降低CCA的化疗剂量。这些发现表明其对感染和CCA具有双重治疗作用,值得进一步开展体内研究。